Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:32 PM
Ignite Modification Date:
2025-12-24 @ 3:32 PM
NCT ID:
NCT05199792
Eligibility Criteria:
Inclusion Criteria:
* Male or female subjects 18-89 years of age
* Suspected or diagnosed vascular disease
* Standard of care carotid, chest, or
* Willingness to undergo 1 research MRA with up to double dose gadoterate meglumine
* Able to complete the MR safety questionnaire
* Able to comprehend and provide informed consent in English
Exclusion Criteria:
* • Allergy to gadolinium-containing contrast media
* Chronic, severe kidney disease
* eGFR \< 60mL/min/1.73m2
* Acute kidney injury
* Kidney or liver transplant within 8 weeks
* Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions)
* Pregnant or breastfeeding women
* Adults unable to consent
* Individual who are not yet adults
* Prisoners
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT05199792
Study Brief:
Protocol Section:
NCT05199792